Register Now: Image-Based Risk: The Next Frontier in Breast Cancer Screening
|Articles|August 22, 2011

CT Scans for Lung Nodules OK at Just 3% of Typical Dose

Author(s)Todd Neff

Radiation doses as low as one-thirtieth of the typical exposure are enough for follow-up screening of lung modules, according to a new study in the September edition of the American Journal of Roentgenology.

Radiation doses as low as one-thirtieth of the typical exposure are enough for follow-up screening of lung modules, according to a new study in the September edition of the American Journal of Roentgenology.

The study, conducted at the Stanford University and the University of Bern in Switzerland, found that tube current-time settings could be as low as 10mAs - well below the standard 100 to 300 mAs - without compromising diagnostic image quality. Lower tube current-time settings mean a sharp drop in radiation dose. That’s particularly important for patients with lung nodules, who often undergo repeated CT scans to monitor for lung cancer, the researchers said.

“The risk of radiation induced cancer death for one standard chest CT is estimated at roughly one in 4,000 and could be reduced hypothetically to one in 120,000 with this low dose protocol,” said radiologist Andreas Christe, MD, of the University of Bern, a lead author of the study.

Three radiologists reviewed chest CT images of 50 patients. The images had been reconstructed at different dose levels. The radiologists were able to identify an average 88 percent of the lung nodules at 10 mAs compared to an average 91 percent at 300 mAs.

In his clinical practice, Christe monitors lung modules at 40 mAs because the study used dose simulations and smaller fields of view than is routine in clinical practice. But pending the results of a follow-up clinical study, he may reduce dose further, he said.

The study also found that computer-aided volume measurement in the follow-up of lung nodules decreased the variability found when radiologists did the measurements manually.
 


Related to this article

Emerging Research Insights and New Advances in Neuroradiology
Catch up on key neuroradiology news and research from the past month, including recently published studies involving white matter hyperintensity findings on brain MRI, MRI-enhanced amyloid PET and the newly FDA-approved PET agent floretyrosine F18 for glioma imaging.
Current Perspectives on Integrating AI into Radiology
In a recent interview with Diagnostic Imaging, Joseph Cavallo, MD, MBA, offered insights on post-deployment monitoring with AI, the potential for improved workflow efficiency and the ongoing challenge of balancing essential clinical skills and AI literacy in the training of radiology residents and fellows.